Pharmacokinetics of oral cyclosporin A when co-administered to enhance theoral absorption of paclitaxel

Citation
Mm. Malingre et al., Pharmacokinetics of oral cyclosporin A when co-administered to enhance theoral absorption of paclitaxel, ANTI-CANC D, 12(7), 2001, pp. 591-593
Citations number
13
Categorie Soggetti
Pharmacology,"Onconogenesis & Cancer Research
Journal title
ANTI-CANCER DRUGS
ISSN journal
09594973 → ACNP
Volume
12
Issue
7
Year of publication
2001
Pages
591 - 593
Database
ISI
SICI code
0959-4973(200108)12:7<591:POOCAW>2.0.ZU;2-V
Abstract
The objective of this study was to evaluate the pharmacokinetics of oral cy closporin A (CsA) when co-administered to enhance the oral absorption of pa clitaxel. Patients received oral paclitaxel in doses of 60-360 mg/m(2) in c ombination with a dose of oral CsA of 15 mg/kg. Dose escalation of paclitax el from 60 to 300 mg/m(2) resulted in a significant decrease in the area un der the concentration-time curve (AUC) of CsA from 24.4 +/- 9.9 to 17.6 +/- 2.8 mg/l.h (p=0.03) (n=28). In conclusion, Increases in the paclitaxel dos e resulted in a decrease In the AUC of CsA. This observation may be explain ed by the increase in the co-solvent Cremophor EL of paclitaxel causing red uced absorption of CsA. [(C) 2001 Lippincott Williams & Wilkins.].